610
Participants
Start Date
April 19, 2021
Primary Completion Date
September 23, 2023
Study Completion Date
September 23, 2023
Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
intramuscular injection, proposed as a series of two doses (0.5 mL each), dosing is 100 microgram on day 0 and day 28
Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
intramuscular injection, proposed dosing is 30 microgram of the diluted vaccine solution (0.3 mL each) on day 0 and day 21
University Hospital Lausanne CHUV, Lausanne
University Hospital Bern, Bern
University Hospital Basel, Basel
University Hospital Zurich, Zurich
Swiss National Science Foundation
OTHER
ModernaTX, Inc.
INDUSTRY
University Hospital, Basel, Switzerland
OTHER